5 (153) In stock
Crowther and Dolton et al. identified an unconventional human T cell clone capable of killing many different types of cancer in vitro in an HLA-independent fashion while sparing healthy cells. Using genome-wide CRISPR-Cas9 screening, the researchers showed that the T cell clone recognized the ubiquitously expressed, mostly monomorphic, MHC-I-related protein MR1 on the surface of cancer cells when MR1 was loaded with a yet unidentified cancer-specific or cancer-associated ligand. Adoptive transfer of this T cell clone into immunodeficient NSG mice with leukemia reduced tumor burden and increased survival.
Dr Ying-Xian Pan - The Holy Grail of Safer Opioids: Targeting Mu
Cancers, Free Full-Text
Cancer detection predicts tumors before they form: discovery
Why T cells - Pan Cancer T
Targeted protein degraders from an oncologist point of view: The
The holy grail: pan-cancer-targeting T cells
A systematic study of novel drug delivery mechanisms and treatment
Michael G King Jr (@MichaelGKingJr) / X
Public and private SARS-CoV-2 T cell receptors may be crucial for
Role of nanotechnology and gene delivery systems in TRAIL based
Cancers, Free Full-Text
Michael G King Jr (@MichaelGKingJr) / X
Genetic and pharmaceutical targeting of HIF1α allows combo
